Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Empagliflozin/metformin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Empagliflozin 12.5mg / Metformin 1g tablets
0601023ARAAADAD
|
Empagliflozin/metformin | Empagliflozin/metformin | Endocrine System | 17,573 |
|
Empagliflozin 5mg / Metformin 1g tablets
0601023ARAAABAB
|
Empagliflozin/metformin | Empagliflozin/metformin | Endocrine System | 10,388 |
|
Empagliflozin 5mg / Metformin 850mg tablets
0601023ARAAAAAA
|
Empagliflozin/metformin | Empagliflozin/metformin | Endocrine System | 1,529 |
|
Empagliflozin 12.5mg / Metformin 850mg tablets
0601023ARAAACAC
|
Empagliflozin/metformin | Empagliflozin/metformin | Endocrine System | 1,369 |
|
Synjardy 12.5mg/1000mg tablets
0601023ARBBADAD
|
Synjardy | Empagliflozin/metformin | Endocrine System | 566 |
|
Synjardy 5mg/1000mg tablets
0601023ARBBABAB
|
Synjardy | Empagliflozin/metformin | Endocrine System | 349 |
|
Synjardy 12.5mg/850mg tablets
0601023ARBBACAC
|
Synjardy | Empagliflozin/metformin | Endocrine System | 96 |
|
Synjardy 5mg/850mg tablets
0601023ARBBAAAA
|
Synjardy | Empagliflozin/metformin | Endocrine System | 65 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.